List of all articles filed under “ivory-coast-report” category.
Jérémie N’Gouan, Head of Pigier Côte d’Ivoire
Jérémie N’Gouan gives an overview of the education system in Côte d’Ivoire and presents Pigier, mentioning some of the school’s advantages, strategy and main projects. Mr N’Gouan also talks about possible partnerships and shares his vision for the development of the country in the coming years.
Nongolougo Soro, CEO of SNDI (Société Nationale de Développement Informatique), talks about the missions SNDI has been given by the government of Côte d’Ivoire, since its creation in 1999.
Kadi Fadika-Coulibaly, CEO of Hudson, an independant securities firm founded in 1995, gives an overview of the market in Côte d’Ivoire and presents the company.
Founded by Moustapha Khalil in 1972, Eurofind is present in diverse markets and activities such as steel, PVC, food products and beverages. The group is present in 8 countries in Europe and Asia, and in 7 countries in Africa, including Côte d’Ivoire.
Profil de Cipharm, une entreprise ivoirienne devenue le fabriquant numéro 1 de produits pharmaceutiques en Côte d’Ivoire depuis sa création en 1988.
La Société Ivoirienne de Manutention et de Transit (SIMAT) entend passer de prestataire en manutention et logistique à leader dans la chaine d’approvisionnement grâce à un partenariat avec NileDutch, la ligne maritime Néerlandaise.
Stéphane Eholie, Chief Executive Officer of SIMAT (Société Ivoirienne de Manutention et de Transit)
Stéphane Eholie gives an evaluation of the logistics sector, mentioning the competition, SIMAT’s differentials, the areas to be developped and the importance of quality and social responsibility. Mr Eholie also shares his vision for the future of Côte d’Ivoire in the coming years.
Ibrahim Diawara, President and CEO of Cipharm, explains why a foreign investor interested in coming to Côte d’Ivoire should invest within the company. Mr Diawara also shares his vision for Cipharm in the coming years.
Ibrahim Diawara talks about the challenges of Cipharm and the pharmaceutical industry as a whole in Côte d’Ivoire, mentioning the problem of strong competition coming from imported products by famous international pharmaceutical groups.
Ibrahim Diawara, President and CEO of Cipharm, gives an overview of the company’s future plans of launching a third unit to produce injectable medicines and doubling its turnover by 2020. Mr Diawara also talks about investment opportunities within Cipharm, saying that the company is open to offers from investors.
